Jeffrey Hung
Stock Analyst at Morgan Stanley
(0)
# 4339
Out of 5,218 analysts
239
Total ratings
46.39%
Success rate
-9.18%
Average return
Main Sectors:
Top Industries:
Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
PTC Therapeutics | Upgrades: Overweight | 45 67 | 46.45 | 44.24% | 10 | Dec 13, 2024 | |
Amicus Therapeutics | Downgrades: Equal-Weight | 17 12 | 9.36 | 28.21% | 4 | Dec 13, 2024 | |
Bioage Labs | Initiates Coverage On: Overweight | 40 | n/a | n/a | 1 | Oct 21, 2024 | |
Intra-Cellular Thera... | Maintains: Overweight | 92 95 | 83.02 | 14.43% | 5 | Oct 11, 2024 | |
Centessa Pharmaceuti... | Upgrades: Overweight | 11 26 | 16.58 | 56.82% | 1 | Sep 19, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 40 40 | 6.07 | 558.98% | 2 | Sep 11, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Equal-Weight | 28 20 | 17.3 | 15.61% | 23 | Aug 7, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 35 | 1.91 | 1732.46% | 1 | Jul 26, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 160 150 | 123 | 21.95% | 4 | Jul 12, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 160 170 | 126.68 | 34.2% | 22 | Jul 12, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 50 70 | 53.51 | 30.82% | 2 | May 23, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 25 | 13.74 | 81.95% | 1 | Apr 30, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 75 40 | 64.78 | -38.25% | 5 | Apr 2, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 55 | 28.75 | 91.3% | 1 | Feb 20, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Equal-Weight | 60 90 | 48.66 | 84.96% | 12 | Jan 5, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Equal-Weight | 295 330 | n/a | n/a | 3 | Dec 22, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underweight | 10 4 | 0.8 | 400% | 10 | Dec 19, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underweight | 13 4 | 1.98 | 102.02% | 1 | Dec 19, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Overweight | 29 55 | 55.28 | -0.51% | 10 | Dec 19, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Equal-Weight | 1 4 | 0.55 | 627.27% | 1 | Dec 19, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Equal-Weight | 60 140 | 6.36 | 2101.26% | 1 | Dec 8, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 90 84 | 45.88 | 83.09% | 7 | Nov 3, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 42 40 | 13.8 | 189.86% | 4 | Nov 3, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 14 14 | 1.64 | 753.66% | 3 | Aug 4, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Equal-Weight | 5 5 | 1.87 | 167.38% | 1 | Jul 11, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 9 3 | 2.23 | 34.53% | 8 | Mar 20, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 15 14 | 1.76 | 695.45% | 7 | Feb 27, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 42 21 | n/a | n/a | 4 | Feb 3, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 27 19 | 11.77 | 61.43% | 5 | Feb 3, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Overweight | 15 | 2.56 | 485.94% | 2 | Feb 3, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underweight | 4 2 | n/a | n/a | 3 | Feb 3, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underweight | 50 10 | 2.25 | 344.44% | 3 | Jan 30, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 22 30 | n/a | n/a | 6 | Jan 10, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 23 22 | 35.01 | -37.16% | 10 | Nov 2, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 2 2 | n/a | n/a | 5 | Sep 9, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Underweight | 250 94 | n/a | n/a | 8 | Jul 15, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 146 149 | 38.47 | 286.02% | 2 | May 11, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Equal-Weight | 180 | n/a | n/a | 12 | Oct 1, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underweight | 100 60 | 3.19 | 1780.88% | 5 | Aug 13, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 7 6 | 6.25 | -4% | 9 | Apr 19, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Equal-Weight | 121 225 | n/a | n/a | 9 | Oct 6, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 58 54 | 1.08 | 4900% | 6 | May 8, 2020 |